Biohaven Ltd. (BHVN)
12.92
-0.28
(-2.08%)
USD |
NYSE |
Sep 25, 11:19
Biohaven Market Cap : 1.950B for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 24, 2026 | 1.992B |
| September 23, 2026 | 2.064B |
| September 22, 2026 | 2.243B |
| September 21, 2026 | 2.147B |
| September 18, 2026 | 2.057B |
| September 17, 2026 | 2.098B |
| September 16, 2026 | 1.815B |
| September 15, 2026 | 1.864B |
| September 14, 2026 | 1.909B |
| September 11, 2026 | 1.919B |
| September 10, 2026 | 1.932B |
| September 09, 2026 | 2.265B |
| September 08, 2026 | 2.223B |
| September 04, 2026 | 2.369B |
| September 03, 2026 | 2.395B |
| September 02, 2026 | 2.369B |
| September 01, 2026 | 2.377B |
| August 31, 2026 | 2.306B |
| August 28, 2026 | 2.327B |
| August 27, 2026 | 2.434B |
| August 26, 2026 | 2.560B |
| August 25, 2026 | 2.172B |
| August 24, 2026 | 2.066B |
| August 21, 2026 | 2.092B |
| August 20, 2026 | 2.039B |
| Date | Value |
|---|---|
| August 19, 2026 | 2.135B |
| August 18, 2026 | 2.049B |
| August 17, 2026 | 2.184B |
| August 14, 2026 | 2.211B |
| August 13, 2026 | 2.243B |
| August 12, 2026 | 2.173B |
| August 11, 2026 | 2.188B |
| August 10, 2026 | 2.196B |
| August 07, 2026 | 2.214B |
| August 06, 2026 | 2.178B |
| August 05, 2026 | 2.051B |
| August 04, 2026 | 2.069B |
| August 03, 2026 | 2.012B |
| July 31, 2026 | 2.032B |
| July 30, 2026 | 2.080B |
| July 29, 2026 | 2.021B |
| July 28, 2026 | 2.072B |
| July 27, 2026 | 2.184B |
| July 24, 2026 | 2.155B |
| July 23, 2026 | 2.205B |
| July 22, 2026 | 2.220B |
| July 21, 2026 | 2.334B |
| July 20, 2026 | 2.237B |
| July 17, 2026 | 2.324B |
| July 16, 2026 | 2.133B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.5062M |
| Brainstorm Cell Therapeutics, Inc. | 10.48M |
| Summit Therapeutics, Inc. | 12.89B |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 194.09M |
Market Cap Related Metrics
| Price to Book Value | 159.58 |
| Price | 12.92 |
| Earnings Yield | -35.97% |